News

WorkersCompensation.com Expert’s View Features Phil Walls on Key Drug Trends


Expert’s View is a regular feature on WorkersCompensation.com that shares insights and opinions from leaders and stakeholders in the workers’ comp industry. After the launch of the 2019 myMatrixx Drug Trend Report, our Chief Clinical Officer, Phil Walls, published an article detailing some of the important findings the report contains. The piece, entitled “Five Workers’ …

myMatrixx Delivers 6.1% Decrease in U.S. Workers’ Compensation Plan Drug Spending


Workers’ compensation pharmacy spending decreased by 6.1% in 2019, according to new data released today by myMatrixx. Through customized solutions that focus on patient safety and clinical care, myMatrixx provides monitoring and clinical intervention at all phases during the life of a workers’ compensation claim. “Helping our clients balance appropriate care for injured workers while …

Phil Walls Discusses Drug Trend Report Launch in WorkCompWire Article


In an article for industry publication WorkCompWire, myMatrixx Chief Clinical Officer, Phil Walls, highlighted the key stories and trends coming out of the release of the 2019 Drug Trend Report. The annual report, released on July 8th, provides an in-depth analysis of pharmaceutical data in the workers’ compensation sector. Through this publication, myMatrixx aims to …

Update on Dexamethasone Use for COVID-19 Treatment


Preliminary results from a randomized, controlled, open-label, adaptive study on the use of dexamethasone were added to myMatrixx’s “Coronavirus Disease 2019 (COVID-19) – The Search for a Treatment” document. The recovery trial compared a ten day course of dexamethasone 6mg once per day versus standard hospital care for COVID-19 patients. Among the population receiving the …